Treatment of glioblastoma stem cell-engrafted mice with allogeneic NK cells in combination with inhibitors of integrin or transforming growth factor (TGF)-β signaling or with TGFBR2 gene-edited allogeneic NK cells prevented NK cell dysfunction and tumor growth [11]. This evidence concerns the gene TGFBR2 and glioblastoma.